Eur Rev Med Pharmacol Sci 2020; 24 (12): 6589-6596

DOI: 10.26355/eurrev_202006_21644

VASN promotes proliferation of prostate cancer through the YAP/TAZ axis

F.-L. Cui, A.-N. Mahmud, Z.-P. Xu, Z.-Y. Wang, J.-P. Hu

Department of Urology Surgery, Affiliated People’s Hospital of Jiangsu University, Zhenjiang, China. 249056614@qq.com


OBJECTIVE: The purpose of this study was to uncover the role of VASN in regulating proliferative ability of prostate cancer (PCa) cells through the yes-associated protein/transcriptional coactivator with PDZ-binding motif (YAP/TAZ) axis, thus influencing the progression of PCa.

PATIENTS AND METHODS: VASN, YAP, and TAZ levels in PCa tissues or in the serum were detected by quantitative Real Time-Polymerase Chain Reaction (qRT-PCR). The diagnostic value of VASN in PCa was assessed by introducing receiver operating characteristic (ROC) curves. Besides, the regulatory effects of VASN on viability, clonality, and expression levels of YAP/TAZ were evaluated by cell counting kit-8 (CCK-8), colony formation, and Western blot, respectively. Finally, rescue experiments were conducted to uncover the involvement of YAP in VASN-regulated proliferation of PCa.

RESULTS: Results manifested that VASN, YA, and TAZ were upregulated in PCa patients, and VASN presented a certain diagnostic value. Knockdown of VASN in LNCaP and C4-2 cells suppressed viability and clonality, and downregulated protein levels of YAP and TAZ. Notably, overexpression of YAP abolished the attenuated viability and clonality in PCa cells with VASN knockdown.

CONCLUSIONS: VASN promotes proliferative ability in PCa via regulating the YAP/TAZ axis, thus aggravating the progression of the disease.

Free PDF Download

To cite this article

F.-L. Cui, A.-N. Mahmud, Z.-P. Xu, Z.-Y. Wang, J.-P. Hu
VASN promotes proliferation of prostate cancer through the YAP/TAZ axis

Eur Rev Med Pharmacol Sci
Year: 2020
Vol. 24 - N. 12
Pages: 6589-6596
DOI: 10.26355/eurrev_202006_21644